• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 69-83 of 153 results

1019 Exhibit: Ex 1019 Plaintiffs Validity Contentions from Amarin Pharma, Inc v Hik...

Document IPR2022-00215, No. 1019-23 Exhibit - Ex 1019 Plaintiffs Validity Contentions from Amarin Pharma, Inc v Hikma Pharms USA Inc, No 16 2525 D Nev Part 2 (P.T.A.B. Nov. 30, 2021)

cite Cite Document
Analyze

1034 Exhibit: Ex 1034 World Health Organization Memorandum, Classification of H...

Document IPR2022-00215, No. 1034-39 Exhibit - Ex 1034 World Health Organization Memorandum, Classification of Hyperlipoproteinemias, 43891, 501 508 1972 (P.T.A.B. Nov. 30, 2021)

cite Cite Document
Analyze

1018 Exhibit: Ex 1018 Day 7 Jan 28, 2020 Trial Transcript from Amarin Pharma, Inc...

Document IPR2022-00215, No. 1018-19 Exhibit - Ex 1018 Day 7 Jan 28, 2020 Trial Transcript from Amarin Pharma, Inc v Hikma Pharms USA Inc, No 16 2525 D Nev Testimony of Dr Toth (P.T.A.B. Nov. 30...

cite Cite Document
Analyze

1046 Exhibit: Ex 1046 Joint Claim Construction Chart from Amarin Pharma, Inc et a...

Document IPR2022-00215, No. 1046-51 Exhibit - Ex 1046 Joint Claim Construction Chart from Amarin Pharma, Inc et al vs Hikma Pharms USA Inc et al, CA No 20 1630 D Del (P.T.A.B. Nov. 30, 2021)

cite Cite Document
Analyze

1021 Exhibit: Ex 1021 Plaintiffs Opposition to Motion to Dismiss from Amarin Pharm...

Document IPR2022-00215, No. 1021-26 Exhibit - Ex 1021 Plaintiffs Opposition to Motion to Dismiss from Amarin Pharma, Inc et al vs Hikma Pharms USA Inc et al, CA No 20 1630 D Del (P.T.A.B. Nov. 30, 2...

cite Cite Document
Analyze

1002 Exhibit: Ex 1002 Expert Declaration of Edward A Fisher, MD, PhD, MPH

Document IPR2022-00215, No. 1002-55 Exhibit - Ex 1002 Expert Declaration of Edward A Fisher, MD, PhD, MPH (P.T.A.B. Nov. 30, 2021)

cite Cite Document
Analyze

1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 6

Document IPR2022-00215, No. 1013-61 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 6 (P.T.A.B. Nov. 30, 2021)

cite Cite Document
Analyze

1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 3

Document IPR2022-00215, No. 1013-58 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 3 (P.T.A.B. Nov. 30, 2021)

cite Cite Document
Analyze

1008 Exhibit: Ex 1008 Third Report of the National Cholesterol Education Program ...

Document IPR2022-00215, No. 1008-8 Exhibit - Ex 1008 Third Report of the National Cholesterol Education Program N CEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholestero...

cite Cite Document
Analyze

1026 Exhibit: Ex 1026 Davidson et al, Efficacy and Tolerability of Adding Prescriptio...

Document IPR2022-00215, No. 1026-31 Exhibit - Ex 1026 Davidson et al, Efficacy and Tolerability of Adding Prescription Omega 3 Fatty Acids 4 gd to Simvastatin 40 mgd in Hypertriglyceridemic Patients (...

cite Cite Document
Analyze

1024 Exhibit: Ex 1024 Exhibit V to Plaintiffs First Amended Complaint, Bhatt et al, C...

Document IPR2022-00215, No. 1024-29 Exhibit - Ex 1024 Exhibit V to Plaintiffs First Amended Complaint, Bhatt et al, Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia, 3801 N E...

cite Cite Document
Analyze

1022 Exhibit: Ex 1022 Plaintiffs First Amended Complaint from Amarin Pharma, Inc...

Document IPR2022-00215, No. 1022-27 Exhibit - Ex 1022 Plaintiffs First Amended Complaint from Amarin Pharma, Inc et al vs Hikma Pharms USA Inc et al, CA No 20 1630 D Del DI17 (P.T.A.B. Nov. 30, 20...

cite Cite Document
Analyze

1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 7

Document IPR2022-00215, No. 1013-62 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 7 (P.T.A.B. Nov. 30, 2021)

cite Cite Document
Analyze

1013 Exhibit: Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 12

Document IPR2022-00215, No. 1013-67 Exhibit - Ex 1013 Expert Declaration of Sylvia Hall Ellis, PhD Part 12 (P.T.A.B. Nov. 30, 2021)

cite Cite Document
Analyze

1042 Exhibit: Ex 1042 US Patent No 7,119,118 to Peet et al

Document IPR2022-00215, No. 1042-47 Exhibit - Ex 1042 US Patent No 7,119,118 to Peet et al (P.T.A.B. Nov. 30, 2021)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 9 10 11 >>